Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Por Sahmoud, T, Hoctin-Boes, G, Modigliani, R, Bitoun, A, Colombel, J F, Soule, J C, Florent, C, Gendre, J P, Lerebours, E, Sylvester, R
Publicado em 1995

Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer

Por Appels, N M G M, Bolijn, M J, Chan, K, Stephens, T C, Hoctin-Boes, G, Middleton, M, Beijnen, J H, de Bono, J S, Harris, A L, Schellens, J H M
Publicado em 2008